Showing posts with label inhibitor of vascular endothelial growth factor (VEGF) receptor. Show all posts
Showing posts with label inhibitor of vascular endothelial growth factor (VEGF) receptor. Show all posts
Tuesday, May 21, 2013

Experimental drug beneficial in trial to treat a rare sarcoma

›
We know that,  Cediranib (tentative trade name Recentin ), also known as AZD2171, is a potent inhibitor of vascular endothelial growth fa...